Skip to content

Improvement of primary care for patients with chronic heart failure: comparing two strategies.

Improvement of primary care for patients with chronic heart failure: A cluster randomised controlled trial comparing two strategies

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN18812755
Enrollment
600
Registered
2010-07-16
Start date
2010-06-01
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure in primary care Circulatory System Heart failure

Interventions

We offer two implementation programmes: standardised and tailored. 1. Standardised delivery of the implementation programme The implementation programme comprises of e

Sponsors

Stichting Robuust (Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The study population will consist of 60 general practitioners (GPs) recruited in the south of the Netherlands. GPs will be contacted either direct or indirect via various regional organisations by advisors of the regional supportive structures for primary care. GPs will include those chronic heart failure patients from their practices of whom the GPs consider themselves to be the physician taking care of the treatment of this condition in the patient, expecting 8 to 10 patients per practice.

Exclusion criteria

Exclusion criteria: 1. GPs: None 2. Patients: 2.1. Those exclusively experiencing secondary care for their chronic heart failure 2.2. < 18 years of age

Design outcomes

Primary

MeasureTime frame
1. Patient's experience of receiving structured primary care for CHF (Patient Assessment of Chronic Illness Care [PACIC]) PACIC is a questionnaire consisting of 27 items, which is related to the Chronic Care Model, which we translated and validated for use in general practice in The Netherlands. 2. Patients' health-related utilities (EQ-5D) EQ-5D consists of 5 questions and a Visual Analogue Scale (VAS).

Secondary

MeasureTime frame
We will examine both changes within groups and differences at follow-up between groups with respect to: 1. Percentage of patients on the maximum tolerated dosage of ACE inhibitor or ARB and of beta blockage 2. Medication completed according to the guideline 3. Percentage of patients receiving of influenza vaccination in the winter season 2010-2011 4. Percentage of patients receiving professionally guided physical activity training 5. Number of non pharmaceutical issues addressed If possible, subgroup analyses will comprise type of heart failure (systolic or diastolic) and diagnostic certainty (secondary care diagnosis, echocardiography diagnosis). Interviews will be used to assess the feasibility of the programme and goal attainment, organisational changes in CHF care, and formalised cooperation with other primary care disciplines and specialist care.

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 29, 2026